Basil Alsikafi

I and White Brook Capital are being impersonated on WhatsApp. I only use WhatsApp to schedule doubles tennis matches and receive youtube videos from my mother. Thanks whitebrookcapital.com/whats-app-poli…

Cash flow to hit ~9mm in quarterly cash flow to breakeven. Validations is a scale game, you're paying of people, if you're installing 3+ on 1 site, you're cash flowing, if not, not. Maint is 80% gross margin. The others are the ball game... $RPID

Directionally correct. Not precisely though. I'm frustrated with their disclosure. 1 of 1. $RPID

@shmilylt I'd be surprised if guidance isn't tightened towards the top of the range. It's overly conservative. They said as much on 1Q call. Margins - they appear to have confidence in their ability to deliver. I think it's malpractice to not disclose more and have told them so.

@Balsikafi If management can give some color on equity issue, things could be better. But anyway business is as normal and hopelfully they can achieve annual guidance, margins particularly

$RPID 1Q summary: Inline-pos. Rec rev up 30%. No one-offs. Mgmt v pos, usually too conservative. MM service agmt signals greater closeness. Stock low - fears of equity raise between now and late 2027. Cost step down this quarter coincides with accelerating growth. 2Q big qtr

@shmilylt It certainly trades like that. From a stock perspective it might make sense to issue equity so people can buy the news. Stock trades silly at this point in my view, but unlike some of the others in this summary series, I own this one.

@Balsikafi Equity rasie is the basic assumption, isn't it?

Selena Meyer would be proud!

$SSTI 1Q Sum: Hospital, drone, bundle selling. Rev down. Cleveland renewed, Puerto Rico, not yet. Safepoint huge cost center, no rev, b/e in 2028. Q1 least profitable of year. Gulf between narrative and Q&A. Churn expected to be higher.

$BOF 1Q Sum: Dairy growth focus. Q2 big delivery qtr vs Q1 - tough qtr. Hard to know what's opportunity vs won, gp vs profit. Mixed fruit, big. Pushed out rev to 27. Trader joes (6-7mm), target (none??), outsourced (6-7mm) opportunities. Lots of options, unclear how real

$BCHT 1Q Summ: Pursuing cert defendents for $80mm. Customer coal plants supported by strong power demand. USe proceeds to scale up water bus. Working with consultants to sell. Will be acquiring in next two months. PFAS building quickly and continuing to grow.

$PESI 1Q summary (late): Everything is taking a little longer than expected. Equity issuance takes financing risk off the table. Execution on nuclear side is going well and that part seems still set up for a significant ramp on a per share basis.

Should be very little room for surprise today in $RPID . Cost improvements are a 2Q event. They reported 4Q late in the quarter so there's little positive or negative room on machines....2Q should be where it begins to get fun stock wise.

@corporalCocoPuf I'll be listening, not attending.

$CCLD 1Q summary: Business humming. Mentioned an ATM program. Only later added stock at $5 to use if needed. Many believe ATMs used if there. Caps upside. I don't agree with the reaction, but foreseeable...even if it was announced a month ago. Informs about mindset of stock owners.

$CDXS 1Q summary: Execution solid. The probability of executing on the option value continues to rise. If 1 hits the stock is a multibagger. There are many. Will know before end of year.

@ValueCompor9 Yea that was a bad performance for a new CEO though. He was opaque and hand wavy, no real answers. I hope the rethink of how they do things, not just what they do happens quickly - for their sake.

@Balsikafi I think it's a positive. Newer CEO too. Hopefully they can get things straightened out.

Given everything at $PTLO is a new CFO bad? I'd lost confidence in that part of the operation.

I don't think $CCLD sellers understand the importance of redeeming the preferred. Before, anytime $CCLD generated extra FCF, it accelerated the preferred's payback. Preferred captured value, common won but only derivatively. Now it's direct. Common wins no mitigants.